Pivotal bioVenture Partners Investment Advisor’s Akouos Inc AKUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,794,088
Closed -$12.1M – 11
2022
Q3
$12.1M Hold
1,794,088
– – 4.43% 4
2022
Q2
$8.41M Hold
1,794,088
– – 4.24% 6
2022
Q1
$8.52M Hold
1,794,088
– – 4.03% 7
2021
Q4
$15.3M Hold
1,794,088
– – 6.38% 5
2021
Q3
$20.8M Hold
1,794,088
– – 7.36% 5
2021
Q2
$22.5M Hold
1,794,088
– – 8.87% 5
2021
Q1
$24.9M Hold
1,794,088
– – 7.98% 5
2020
Q4
$35.6M Buy
+1,794,088
New +$35M 11.73% 3

Pivotal bioVenture Partners Investment Advisor's AKUS Position: Q4 2022 in Review

Pivotal bioVenture Partners Investment Advisor sold out of Akouos Inc (AKUS) in Q4 2022, closing a stake of 1,794,088 shares — an estimated $12.1M sold.

Pivotal bioVenture Partners Investment Advisor first reported a position in AKUS in Q4 2020 and held it in 8 quarters. The position peaked at $35.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold AKUS as of Q4 2022.

  • Pivotal bioVenture Partners Investment Advisor reported no remaining Akouos Inc position as of Q4 2022 after selling out during the quarter.
  • Pivotal bioVenture Partners Investment Advisor sold 1,794,088 Akouos Inc shares in Q4 2022, an estimated $12.1M.
  • Pivotal bioVenture Partners Investment Advisor first reported a position in Akouos Inc in Q4 2020 and held it in 8 quarters.
  • Pivotal bioVenture Partners Investment Advisor's Akouos Inc position peaked at $35.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Akouos Inc as of Q4 2022.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2022, filed 13 Feb 2023.